 | • レポートコード：QY2207C0713 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のカンレノンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカンレノンの世界市場のxxx％を占める「純度99％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「心臓浮腫」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のカンレノンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカンレノン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのカンレノン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 カンレノンのグローバル主要メーカーには、Midas Pharma、Zhejiang Shenzhou Pharmaceutical、EUROAPI、VIOCHEMICALS、Zhejiang Langhua Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 カンレノン市場は、種類と用途によって区分されます。世界のカンレノン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度99％以上、純度99％以下 【用途別セグメント】 心臓浮腫、肝硬変腹水 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - カンレノン製品概要 - 種類別市場（純度99％以上、純度99％以下） - 用途別市場（心臓浮腫、肝硬変腹水） - 調査の目的 ・エグゼクティブサマリー - 世界のカンレノン販売量予測2017-2028 - 世界のカンレノン売上予測2017-2028 - カンレノンの地域別販売量 - カンレノンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別カンレノン販売量 - 主要メーカー別カンレノン売上 - 主要メーカー別カンレノン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度99％以上、純度99％以下） - カンレノンの種類別販売量 - カンレノンの種類別売上 - カンレノンの種類別価格 ・用途別市場規模（心臓浮腫、肝硬変腹水） - カンレノンの用途別販売量 - カンレノンの用途別売上 - カンレノンの用途別価格 ・北米市場 - 北米のカンレノン市場規模（種類別、用途別） - 主要国別のカンレノン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのカンレノン市場規模（種類別、用途別） - 主要国別のカンレノン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のカンレノン市場規模（種類別、用途別） - 主要国別のカンレノン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のカンレノン市場規模（種類別、用途別） - 主要国別のカンレノン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのカンレノン市場規模（種類別、用途別） - 主要国別のカンレノン市場規模（トルコ、サウジアラビア） ・企業情報 Midas Pharma、Zhejiang Shenzhou Pharmaceutical、EUROAPI、VIOCHEMICALS、Zhejiang Langhua Pharmaceutical ・産業チェーン及び販売チャネル分析 - カンレノンの産業チェーン分析 - カンレノンの原材料 - カンレノンの生産プロセス - カンレノンの販売及びマーケティング - カンレノンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - カンレノンの産業動向 - カンレノンのマーケットドライバー - カンレノンの課題 - カンレノンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Canrenone Market
Due to the COVID-19 pandemic, the global Canrenone market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, ≥99% Purity accounting for % of the Canrenone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cardiac Edema segment is altered to an % CAGR throughout this forecast period.
China Canrenone market size is valued at US$ million in 2021, while the US and Europe Canrenone are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Canrenone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Canrenone include Midas Pharma, Zhejiang Shenzhou Pharmaceutical, EUROAPI, VIOCHEMICALS and Zhejiang Langhua Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Canrenone capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Canrenone by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Canrenone Scope and Segment
Canrenone market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Canrenone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
≥99% Purity
＜99% Purity
Segment by Application
Cardiac Edema
Cirrhotic Ascites
By Company
Midas Pharma
Zhejiang Shenzhou Pharmaceutical
EUROAPI
VIOCHEMICALS
Zhejiang Langhua Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Canrenone Product Introduction
1.2 Market by Type
1.2.1 Global Canrenone Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 ≥99% Purity
1.2.3 ＜99% Purity
1.3 Market by Application
1.3.1 Global Canrenone Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiac Edema
1.3.3 Cirrhotic Ascites
1.4 Study Objectives
1.5 Years Considered
2 Global Canrenone Production
2.1 Global Canrenone Production Capacity (2017-2028)
2.2 Global Canrenone Production by Region: 2017 VS 2021 VS 2028
2.3 Global Canrenone Production by Region
2.3.1 Global Canrenone Historic Production by Region (2017-2022)
2.3.2 Global Canrenone Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Canrenone Sales in Volume & Value Estimates and Forecasts
3.1 Global Canrenone Sales Estimates and Forecasts 2017-2028
3.2 Global Canrenone Revenue Estimates and Forecasts 2017-2028
3.3 Global Canrenone Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Canrenone Sales by Region
3.4.1 Global Canrenone Sales by Region (2017-2022)
3.4.2 Global Sales Canrenone by Region (2023-2028)
3.5 Global Canrenone Revenue by Region
3.5.1 Global Canrenone Revenue by Region (2017-2022)
3.5.2 Global Canrenone Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Canrenone Production Capacity by Manufacturers
4.2 Global Canrenone Sales by Manufacturers
4.2.1 Global Canrenone Sales by Manufacturers (2017-2022)
4.2.2 Global Canrenone Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Canrenone in 2021
4.3 Global Canrenone Revenue by Manufacturers
4.3.1 Global Canrenone Revenue by Manufacturers (2017-2022)
4.3.2 Global Canrenone Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Canrenone Revenue in 2021
4.4 Global Canrenone Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Canrenone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Canrenone Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Canrenone Sales by Type
5.1.1 Global Canrenone Historical Sales by Type (2017-2022)
5.1.2 Global Canrenone Forecasted Sales by Type (2023-2028)
5.1.3 Global Canrenone Sales Market Share by Type (2017-2028)
5.2 Global Canrenone Revenue by Type
5.2.1 Global Canrenone Historical Revenue by Type (2017-2022)
5.2.2 Global Canrenone Forecasted Revenue by Type (2023-2028)
5.2.3 Global Canrenone Revenue Market Share by Type (2017-2028)
5.3 Global Canrenone Price by Type
5.3.1 Global Canrenone Price by Type (2017-2022)
5.3.2 Global Canrenone Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Canrenone Sales by Application
6.1.1 Global Canrenone Historical Sales by Application (2017-2022)
6.1.2 Global Canrenone Forecasted Sales by Application (2023-2028)
6.1.3 Global Canrenone Sales Market Share by Application (2017-2028)
6.2 Global Canrenone Revenue by Application
6.2.1 Global Canrenone Historical Revenue by Application (2017-2022)
6.2.2 Global Canrenone Forecasted Revenue by Application (2023-2028)
6.2.3 Global Canrenone Revenue Market Share by Application (2017-2028)
6.3 Global Canrenone Price by Application
6.3.1 Global Canrenone Price by Application (2017-2022)
6.3.2 Global Canrenone Price Forecast by Application (2023-2028)
7 North America
7.1 North America Canrenone Market Size by Type
7.1.1 North America Canrenone Sales by Type (2017-2028)
7.1.2 North America Canrenone Revenue by Type (2017-2028)
7.2 North America Canrenone Market Size by Application
7.2.1 North America Canrenone Sales by Application (2017-2028)
7.2.2 North America Canrenone Revenue by Application (2017-2028)
7.3 North America Canrenone Sales by Country
7.3.1 North America Canrenone Sales by Country (2017-2028)
7.3.2 North America Canrenone Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Canrenone Market Size by Type
8.1.1 Europe Canrenone Sales by Type (2017-2028)
8.1.2 Europe Canrenone Revenue by Type (2017-2028)
8.2 Europe Canrenone Market Size by Application
8.2.1 Europe Canrenone Sales by Application (2017-2028)
8.2.2 Europe Canrenone Revenue by Application (2017-2028)
8.3 Europe Canrenone Sales by Country
8.3.1 Europe Canrenone Sales by Country (2017-2028)
8.3.2 Europe Canrenone Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Canrenone Market Size by Type
9.1.1 Asia Pacific Canrenone Sales by Type (2017-2028)
9.1.2 Asia Pacific Canrenone Revenue by Type (2017-2028)
9.2 Asia Pacific Canrenone Market Size by Application
9.2.1 Asia Pacific Canrenone Sales by Application (2017-2028)
9.2.2 Asia Pacific Canrenone Revenue by Application (2017-2028)
9.3 Asia Pacific Canrenone Sales by Region
9.3.1 Asia Pacific Canrenone Sales by Region (2017-2028)
9.3.2 Asia Pacific Canrenone Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Canrenone Market Size by Type
10.1.1 Latin America Canrenone Sales by Type (2017-2028)
10.1.2 Latin America Canrenone Revenue by Type (2017-2028)
10.2 Latin America Canrenone Market Size by Application
10.2.1 Latin America Canrenone Sales by Application (2017-2028)
10.2.2 Latin America Canrenone Revenue by Application (2017-2028)
10.3 Latin America Canrenone Sales by Country
10.3.1 Latin America Canrenone Sales by Country (2017-2028)
10.3.2 Latin America Canrenone Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Canrenone Market Size by Type
11.1.1 Middle East and Africa Canrenone Sales by Type (2017-2028)
11.1.2 Middle East and Africa Canrenone Revenue by Type (2017-2028)
11.2 Middle East and Africa Canrenone Market Size by Application
11.2.1 Middle East and Africa Canrenone Sales by Application (2017-2028)
11.2.2 Middle East and Africa Canrenone Revenue by Application (2017-2028)
11.3 Middle East and Africa Canrenone Sales by Country
11.3.1 Middle East and Africa Canrenone Sales by Country (2017-2028)
11.3.2 Middle East and Africa Canrenone Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Midas Pharma
12.1.1 Midas Pharma Corporation Information
12.1.2 Midas Pharma Overview
12.1.3 Midas Pharma Canrenone Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Midas Pharma Canrenone Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Midas Pharma Recent Developments
12.2 Zhejiang Shenzhou Pharmaceutical
12.2.1 Zhejiang Shenzhou Pharmaceutical Corporation Information
12.2.2 Zhejiang Shenzhou Pharmaceutical Overview
12.2.3 Zhejiang Shenzhou Pharmaceutical Canrenone Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Zhejiang Shenzhou Pharmaceutical Canrenone Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zhejiang Shenzhou Pharmaceutical Recent Developments
12.3 EUROAPI
12.3.1 EUROAPI Corporation Information
12.3.2 EUROAPI Overview
12.3.3 EUROAPI Canrenone Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 EUROAPI Canrenone Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 EUROAPI Recent Developments
12.4 VIOCHEMICALS
12.4.1 VIOCHEMICALS Corporation Information
12.4.2 VIOCHEMICALS Overview
12.4.3 VIOCHEMICALS Canrenone Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 VIOCHEMICALS Canrenone Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 VIOCHEMICALS Recent Developments
12.5 Zhejiang Langhua Pharmaceutical
12.5.1 Zhejiang Langhua Pharmaceutical Corporation Information
12.5.2 Zhejiang Langhua Pharmaceutical Overview
12.5.3 Zhejiang Langhua Pharmaceutical Canrenone Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Zhejiang Langhua Pharmaceutical Canrenone Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Zhejiang Langhua Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Canrenone Industry Chain Analysis
13.2 Canrenone Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Canrenone Production Mode & Process
13.4 Canrenone Sales and Marketing
13.4.1 Canrenone Sales Channels
13.4.2 Canrenone Distributors
13.5 Canrenone Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Canrenone Industry Trends
14.2 Canrenone Market Drivers
14.3 Canrenone Market Challenges
14.4 Canrenone Market Restraints
15 Key Finding in The Global Canrenone Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer